Condorise Pharmaceuticals Private Limited - Company Profile

It is a healthcare private limited company based in Kolhapur, Maharashtra, India, established in 2020.
2020 Kolhapur, Maharashtra, India Active
Last Updated:
Access Report
About Condorise Pharmaceuticals Private Limited

Condorise Pharmaceuticals Private Limited, a active private limited company, was established on 08 July 2020 in Kolhapur, Maharashtra, India. Engaging in manufacturing within the healthcare sector, it holds CIN: U33100PN2020PTC191800. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Deepali Sachinkumar Mane (Director), Sachinkumar Surendra Mane (Director). Its latest AGM occurred on 31 December 2021, with the balance sheet filed on 31 March 2021. It is based at C/O Surendra Gundu Mane Tal Shirol Akiwat, Kolhapur, Maharashtra, 416106.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33100PN2020PTC191800

  • Registration Number

    191800

  • Incorporation Date

    08 July 2020

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 7 Months
  • Last Filing with ROC 31 Mar 2021
Company report

Condorise Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Condorise Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Condorise Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Deepali Sachinkumar Mane Director 08 Jul 2020 Current
Sachinkumar Surendra Mane Director 08 Jul 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Condorise Pharmaceuticals.

Enhance accessibility to Condorise Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Condorise Pharmaceuticals revenue growth over time
Condorise Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Condorise Pharmaceuticals?

Unlock access to Condorise Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Condorise Pharmaceuticals?

Condorise Pharmaceuticals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Condorise Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Condorise Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Condorise Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Condorise Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2021 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Condorise Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Pune. was completed.

  • Director Appointment

    Progress on Deepali Sachinkumar Mane was appointed as a Director was appointed as a Director on 08 Jul 2020 & has been associated with this company since 5 years 7 months . was documented.

  • Director Appointment

    The activity Sachinkumar Surendra Mane was appointed as a Director was appointed as a Director on 08 Jul 2020 & has been associated with this company since 5 years 7 months . was completed.

  • Company Incorporation

    The activity Condorise Pharmaceuticals Private Limited was registered on 08 Jul 2020 with Roc Pune & aged 5 years 7 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Condorise Pharmaceuticals Private Limited?

The CIN of Condorise Pharmaceuticals Private Limited is U33100PN2020PTC191800.

Where is Condorise Pharmaceuticals Private Limited headquartered?

Condorise Pharmaceuticals Private Limited is headquartered at C/O Surendra Gundu Mane Tal Shirol Akiwat, Kolhapur, Maharashtra, 416106.

When was Condorise Pharmaceuticals Private Limited incorporated?

Condorise Pharmaceuticals Private Limited was incorporated on 08 July 2020.

Who are the current directors of Condorise Pharmaceuticals Private Limited?

The current directors of Condorise Pharmaceuticals Private Limited are

What is the primary industry of Condorise Pharmaceuticals Private Limited?

The primary industry of Condorise Pharmaceuticals Private Limited is Healthcare.

Is Condorise Pharmaceuticals Private Limited a listed company?

Condorise Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Condorise Pharmaceuticals Private Limited?

The authorized capital of Condorise Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available